CNBX Pharmaceuticals Inc.

CNBX Pharmaceuticals Inc.verified

CNBX

Price:

$0.0004

Market Cap:

$37.01K

CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it develops Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids f...[Read more]

Industry

Biotechnology

IPO Date

2007-09-04

Stock Exchange

OTC

Ticker

CNBX

The ROE as of December 2025 (TTM) for CNBX Pharmaceuticals Inc. (CNBX) is 8.89%

According to CNBX Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is 8.89%. This represents a change of 300.41% compared to the average of 2.22% of the last 4 quarters.

CNBX Pharmaceuticals Inc. (CNBX) Historical ROE (quarterly & annually)

How has CNBX ROE performed in the past?

The mean historical ROE of CNBX Pharmaceuticals Inc. over the last ten years is -28.26%. The current 8.89% ROE has changed -131.44% with respect to the historical average. Over the past ten years (40 quarters), CNBX's ROE was at its highest in in the February 2022 quarter at 269.59%. The ROE was at its lowest in in the November 2021 quarter at -210.86%.

Quarterly (TTM)
Annual

Average

-28.26%

Median

10.13%

Minimum

-423.17%

Maximum

228.08%

CNBX Pharmaceuticals Inc. (CNBX) ROE by Quarter and Year

Discovering the peaks and valleys of CNBX Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 116.93%

Maximum Annual ROE = 228.08%

Minimum Annual Increase = -5606.97%

Minimum Annual ROE = -423.17%

Quarterly (TTM)
Annual
YearROEChange
202512.58%-55.12%
202428.02%-84.76%
2023183.91%-19.37%
2022228.08%-228.96%
2021-176.86%-58.21%
2020-423.17%-5606.97%
20197.68%-105.38%
2018-142.76%116.93%
2017-65.81%-200.20%
201665.68%-62.44%

CNBX Pharmaceuticals Inc. (CNBX) Average ROE

How has CNBX ROE performed in the past?

The current ROE of CNBX Pharmaceuticals Inc. (CNBX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

74.84%

5-year avg

55.15%

10-year avg

-28.26%

CNBX Pharmaceuticals Inc. (CNBX) ROE vs. Peers

How is CNBX’s ROE compared to its peers?

CNBX Pharmaceuticals Inc.’s ROE is less than GeneLink, Inc. (147.34%), less than Endonovo Therapeutics, Inc. (9.10%), less than Microart Inc. (0%), greater than RVL Pharmaceuticals plc (-80.88%), less than Acura Pharmaceuticals, Inc. (30.77%), greater than Tian'an Pharmaceutical Co., Ltd. (-4.90%), less than Itoco Inc. (291.99%), greater than Filament Health Corp. (-198.47%), greater than Affymax, Inc. (-420.95%), less than Naturally Splendid Enterprises Ltd. (279.34%),

Build a custom stock screener for CNBX Pharmaceuticals Inc. (CNBX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CNBX Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CNBX Pharmaceuticals Inc. (CNBX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CNBX Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is CNBX Pharmaceuticals Inc.'s ROE?

How is the ROE calculated for CNBX Pharmaceuticals Inc. (CNBX)?

What is the highest ROE for CNBX Pharmaceuticals Inc. (CNBX)?

What is the 3-year average ROE for CNBX Pharmaceuticals Inc. (CNBX)?

What is the 5-year average ROE for CNBX Pharmaceuticals Inc. (CNBX)?

How does the current ROE for CNBX Pharmaceuticals Inc. (CNBX) compare to its historical average?